Prescribing of eplerenone in eligible patients
| n (%) | |
|---|---|
| Moderate or severe LV systolic dysfunction | 32 (19%) |
| Moderate or severe LV systolic dysfunction and symptomatic or diabetes: | 15 (9%) |
| Eplerenone contraindicated | 1 (7%)* |
| Eligible for eplerenone | 14 (8%) |
| Eplerenone appropriately initiated | 3 (21%)* |
↵* Percentage of patients meeting eligibility criteria for eplerenone